Clinical Trial

Familial B-cell Lymphoproliferative Disorders

Study acronym: Familial_LPD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates families with at least two cases of B-cell lymphoproliferative disorders (LPD), and evaluates the prevalence of LPD in families, the relationship between medical history, genetic factors, and the risk of familial LPD, and various clinical outcomes for these families in a multiethnic population of Jews and Arabs in Israel.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-30.
Trial Details
NCT Number NCT05718986
Lead Sponsor University of Haifa
Collaborators: Bnai Zion Medical Center
Conditions Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia
Enrollment 1,000 participants
Start Date 2024-06
Primary Completion 2028-12 (estimated)
Study Completion 2040-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-08